News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Liso-cel is a feasible and effective option for patients with R/R large B cell lymphoma – MD Anderson Cancer Center
mdanderson.org
Dec 11, 2024, 09:53

Liso-cel is a feasible and effective option for patients with R/R large B cell lymphoma – MD Anderson Cancer Center

MD Anderson Cancer Center shared a post on X:

“For patients with relapsed or refractory large B cell lymphoma and secondary central nervous system involvement, Lisocabtagene Maraleucel (liso-cel) is a feasible and effective option, our Dr. Sairah Ahmed reported at ASH24 this morning.”

Liso-cel is a feasible and effective option for patients with R/R large B cell lymphoma - MD Anderson Cancer Center

More posts featuring MD Anderson Cancer Center.

ASH24 cancer Large B-Cell Lymphoma Liso-cel lisocabtagene maraleucel MD Anderson Cancer Center OncoDaily Oncology Sairah Ahmed
Special Coverage
Insight
Dec 11, 2024, 09:53
Thomas Powles was appointed Editor-in-Chief of Annals of Oncology
Blog
Dec 11, 2024, 09:53
Liso-cel is a feasible and effective option for patients with R/R large B cell lymphoma - MD Anderson Cancer Center
Blog
Dec 11, 2024, 09:45
Kelly Meza: Incredible experience with amazing friends and mentors at ASH24
Blog
Dec 11, 2024, 09:42
Alejandra Mendez: Fertility preservation ensuring the best possible quality of life after cancer
Blog
Dec 11, 2024, 09:39
Talha Badar: Presenting several abstracts on acute leukemia and myeloid disorders at ASH24
Insight
Dec 11, 2024, 09:32
Nelson Dusetti: Our project COMBAT-PDAC has secured nearly 2 million euros in funding from the EP PerMed
Blog
Dec 11, 2024, 09:26
Laura Ortiz-Ravick: Proud to have represented The Leukemia and Lymphoma Society at ASH24
Blog
Dec 11, 2024, 09:20
Meet Dr. Stefania Morganti - Dana-Farber’s Breast Oncology Center
Blog
Dec 11, 2024, 09:15
OncoInfluencers to Follow on Social Media: Dr. Mohamed Emam Sobeih
Insight
Dec 11, 2024, 09:10
Fernando Martín Moro: New drugs in DLBCL frontline
Insight
Dec 11, 2024, 08:56
The AQUILA study from ASH24 is out - IACH
Insight
Dec 11, 2024, 08:39
Vivek Subbiah: From novel diagnostics to cutting-edge therapies like Leptomeningeal Metastatic Disease